Tag: Tumor Microenvironment

HalioDx closed a Series B round of €18.5 million (US$22.3 million)

| January 17, 2018 | 0 Comments

This funding will accelerate the development of Immunoscore® in selected cancers, and support set up of commercial activities in the US This round was led by PSIM fund managed by Bpifrance in the framework of the program ‘Investing for the Future’ Marseille, France, January 17, 2018 – HalioDx, a diagnostic company expert in the analysis […]

Continue Reading

Meet OracleBio at ASCO 2016, Chicago, June 4th – 6th – Booth 14114

| June 1, 2016 | 0 Comments

OracleBio, a leading provider of high quality precision histopathology image analysis services to support Pharmaceutical R&D, companion diagnostics development, pathology review and biomarker research, will be exhibiting at the American Society of Clinical Oncology (ASCO) congress 2016 in Chicago from June 4th – 6th. OracleBio combines over 75 years of Pharma R&D experience with expertise […]

Continue Reading